Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 15 September 2021, 08:59 HKT/SGT
Share:
    

Source: NEC Corporation
NEC Utilizes Digital Technologies to Create Healthcare and Life Science Business

TOKYO, Sept 15, 2021 - (JCN Newswire) - NEC Corporation (TSE: 6701) announced today an initiative to create healthcare and life science business that utilizes AI and other digital technologies as part of the "creation of future growth businesses" set forth in the 2025 Mid-term Management Plan. NEC will focus on the three areas of Medical Care, Lifestyle Support, and Life Science, aiming for a business value of 500 billion yen (approximately 4.5 billion USD) in 2030.

Three Areas of Focus and Future Vision

Currently, in the field of healthcare, in addition to the spread of new types of coronavirus, the growing number of people with lifestyle-related illnesses, such as certain forms of cancer, is now a common challenge worldwide. NEC has contributed to the efficiency and sophistication of medical services through the provision of reception systems(1) and electronic medical record systems for more than 50 years. Furthermore, NEC began full-scale entry into the drug discovery business in 2019 (2), with the aim of promoting innovative next-generation medical care based on the results of research activities to date. This new initiative aims to accelerate and expand the healthcare-related business more than ever before and to grow the business toward the creation of social value.

Specifically, NEC will expand business in the following three areas by taking advantage of its leading-edge biometrics technologies, "Bio-Idiom"(3), featuring the world's No. 1 face recognition accuracy(4), as well as its portfolio of leading artificial intelligence technologies, "NEC the WISE"(5), including video analytics and graph-based relationship learning developed by NEC laboratories.

The first area is the "Medical Care" business, featuring digital support for medical care; the second is "Lifestyle Support" business, which helps individuals in their daily lives; and the third is "Life Science" business, which supports personalized medical care with technology. Through these three areas of business, NEC aims to create a world in which individuals may live more freely and comfortably.

In addition, NEC will promote R&D with an eye toward 2030 and the needs of hospitals, nursing care, rehabilitation, and other situations. NEC will also launch the Healthcare and Life Sciences Project Management Office (PMO) to support the acceleration of business development across the NEC Group.

Furthermore, NEC will create new value in the healthcare and life sciences fields through co-creation with a wide range of external partners. In November, for example, NEC will launch NEC Expert Committee on Healthcare and Life Sciences, aiming to implement a future image of society with experts from a variety of positions and perspectives.

NEC aims to support society and the healthcare sciences field through the provision of services and products tailored to individuals, including both consumers and healthcare professionals.

(1) Reception system: System for preparing medical fee statements
(2) NEC's AI Drug Development Business
https://www.nec.com/en/global/solutions/ai-drug/index.html
(3) About Bio-IDiom
https://www.nec.com/en/global/ad/bio-idiom/
(4) Since 2009, NEC has repeatedly been ranked first in the face recognition accuracy evaluation by the National Institute of Standards and Technology (NIST).
https://www.nec.com/en/global/solutions/biometrics/face/index.html
(5) NEC announces new AI technology brand, "NEC the WISE"
https://www.nec.com/en/press/201607/global_20160719_01.html

About NEC Corporation

NEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of "Orchestrating a brighter world." NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com.


Topic: Press release summary
Source: NEC Corporation

Sectors: Digitalization, MedTech
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.


NEC Corporation Links

http://www.nec.com

https://www.facebook.com/nec.global/

https://twitter.com/NEC_corp

https://www.youtube.com/user/NECglobalOfficial

https://www.linkedin.com/company/nec/

NEC Corporation
Feb 21, 2025 13:39 HKT/SGT
NEC Innovation Challenge awards Canada's Prevu3D Inc. with the NEC Award and NOFF Award
Feb 21, 2025 11:00 HKT/SGT
NEC Develops Near Real-time RIC for High Performance 5G vRAN
Feb 19, 2025 19:16 HKT/SGT
NEC X & Carbide Ventures Partner To Rapidly Accelerate Early-Stage Startups
Feb 19, 2025 08:08 HKT/SGT
NEC Orchestrating Future Fund invests in Aetion, a U.S.-based provider of healthcare analytics platforms
Feb 10, 2025 14:05 HKT/SGT
NEC Solution Modernizes Network Infrastructure Construction Work
Jan 29, 2025 09:08 HKT/SGT
NEC combines video analysis technology with generative AI to generate advice for improving work quality
Jan 27, 2025 11:01 HKT/SGT
hootfolio, Inc., a Provider of Causal Analysis Technology, Launches Business Development
Jan 24, 2025 08:19 HKT/SGT
World's First Successful Transmission of Huge Volume Mission Data Using 1.5 micron Optical Inter-Satellite Communication
Jan 17, 2025 11:47 HKT/SGT
NEC Listed on the World Index and Asia Pacific Index of Dow Jones Sustainability Indices (DJSI)
Jan 10, 2025 10:37 HKT/SGT
NEC and Biomy Partner to Develop and Expand AI-Based Analytical Platforms in the Digital Pathology Field
More news >>
 News Alerts
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: